Nicolas Pierre

Nicolas Pierre

Auto-generated profile, based on publicly available information

Nicolas Pierre

Laboratory of Translational Gastroenterology, GIGA-Institute, Liege University, Liege, Belgium

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NPNicolas Pierre
Nicolas Pierre
Louise DeldicqueLouise Deldicque
Louise Deldicque
CBCaroline Barbé
Caroline Barbé
DNDamien Naslain
Damien Naslain
Patrice CaniPatrice Cani
Patrice Cani
MFMarc Francaux
Marc Francaux
The purpose of this study was to investigate whether toll-like receptor 4 (TLR4) is implicated in the development of endoplasmic reticulum stress (ER stress) observed after a high-fat diet (HFD) in liver, skeletal muscle and adipose tissue. TLR4−/− and C57BL/6J wild-type mice (WT) were fed with chow or HFD (45% calories from fat) during 18 weeks. An oral glucose tolerance-test was performed. The animals were sacrificed in a fasted state and the tissues were removed. TLR4 deletion protected from body weight gain and glucose intolerance induced by HFD whereas energy intake was higher in transgenic mice suggesting larger energy expenditure. HFD induced an ER stress in skeletal muscle, liver and adipose tissue of WT mice as assessed by BiP, CHOP, spliced and unspliced XBP1 and phospho-eIF2α. TLR4−/− mice were protected against HFD-induced ER stress. Then, we investigated the main signaling downstream of TLR4 namely the NF-κB pathway, expecting to identify the mechanism by which TLR4 is able to activate ER stress. The mRNA levels of cytokines regulated by NF-κB namely TNFα, IL-1β and IL-6, were not changed after HFD and phospho-IκB-α (ser 32) was not changed. Our results indicate that TLR4 is essential for the development of ER stress related to HFD. Nevertheless, the NFκ-B pathway does not seem to be directly implicated. The reduced fat storage in TLR4−/− mice could explain the absence of an ER stress after HFD.

1 March 2017 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
JRJulie Rodriguez
Julie Rodriguez
NPNicolas Pierre
Nicolas Pierre
DNDamien Naslain
Damien Naslain
FBFrançoise Bontemps
Françoise Bontemps
DFDaneel Ferreira
Daneel Ferreira
MFMarc Francaux
Marc Francaux
Background: The control of muscle size is an essential feature of health. Indeed, skeletal muscle atrophy leads to reduced strength, poor quality of life, and metabolic disturbances. Consequently, strategies aiming to attenuate muscle wasting and to promote muscle growth during various (pathological) physiological states like sarcopenia, immobilization, malnutrition, or cachexia are needed to address this extensive health issue. In this study, we tested the effects of urolithin B, an ellagitannin‐derived metabolite, on skeletal muscle growth.Methods: C2C12 myotubes were treated with 15 μM of urolithin B for 24 h. For in vivo experiments, mice were implanted with mini‐osmotic pumps delivering continuously 10 μg/day of urolithin B during 28 days. Muscle atrophy was studied in mice with a sciatic nerve denervation receiving urolithin B by the same way.Results: Our experiments reveal that urolithin B enhances the growth and differentiation of C2C12 myotubes by increasing protein synthesis and repressing the ubiquitin–proteasome pathway. Genetic and pharmacological arguments support an implication of the androgen receptor. Signalling analyses suggest a crosstalk between the androgen receptor and the mTORC1 pathway, possibly via AMPK. In vivo experiments confirm that urolithin B induces muscle hypertrophy in mice and reduces muscle atrophy after the sciatic nerve section.Conclusions: This study highlights the potential usefulness of urolithin B for the treatment of muscle mass loss associated with various (pathological) physiological states.

1 July 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NPNicolas Pierre
Nicolas Pierre
CBCaroline Barbé
Caroline Barbé
HGHélène Gilson
Hélène Gilson
Louise DeldicqueLouise Deldicque
Louise Deldicque
JRJean-Marc Raymackers
Jean-Marc Raymackers
MFMarc Francaux
Marc Francaux

28 February 2017 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
TCThibault Cavey
Thibault Cavey
NPNicolas Pierre
Nicolas Pierre
KNKévin Nay
Kévin Nay
CACoralie Allain
Coralie Allain
MRMartine Ropert
Martine Ropert
FDFrederic Derbre
Frederic Derbre

1 December 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SCSreeda Chalil
Sreeda Chalil
NPNicolas Pierre
Nicolas Pierre
ABAstrid D. Bakker
Astrid D. Bakker
RMRalph Manders
Ralph Manders
APAnnelies Pletsers
Annelies Pletsers
Louise DeldicqueLouise Deldicque
Louise Deldicque

23 July 2021 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
NPNicolas Pierre
Nicolas Pierre
CSCatherine Salée
Catherine Salée
SVSophie Vieujean
Sophie Vieujean
EBEmeline Bequet
Emeline Bequet
AMAngela‐Maria Merli
Angela‐Maria Merli
ELEdouard Louis
Edouard Louis